01 January 1998
Galectin- and C-type lectin-reactive asialofetuin induces an increase of cytoplasmic pH in implant-colonizing rat macrophages - an ex vivo study
Karel Smetana Jr, Jan Slavik, Hans-Joachim GabiusMed Sci Monit 1998; 4(1): BR20-26 :: ID: 502811
Abstract
The carbohydrate chains of glycoconjugates establish cell surface signatures which are related to recognitive processes. In addition to serving as docking points for receptors such as lectins, the protein-carbohydrate interaction may trigger biosignaling processes in cells, warranting the need to employ model systems for this study. Asialofetuin (ASF) which presents with defined N- and O-linked b-galactoside-terminating oligosaccharide chains with reactivity to C-type lectins and galectins can be used as a model ligand, cell binding and ensuing response(s) to the sugar-specific interaction can be monitored. Due to the clinical relevance of this model our ex vivo experiments were focused on the inflammatory macrophages colonizing the surface of implanted cellophane foil. In addition to the visualization of b-galactoside-binding sites by biotinylated asialofetuin, impact of sugar-dependent probe binding on the cytoplasmic pHi is assayed by fluorescence excitation ratio-imaging microscopy. The experiments revealed pronounced binding of ASF to mononuclear macrophages and foreignbody giant multinucleate cells. Cell surface association of ASF (20 µg/ml) increased the pHi of the cytoplasm of inflammatory macrophages colonizing the surface of the implant relative to human serum albumin used as a carbohydrate free control. Owing to a slight Ca2+-sensitivity of pHi upregulation by ASF, a C-type b-galactoside- recognizing lectin is likely to be involved in this reaction. Since the use of EDTA (an inhibitor of C-type lectins) caused strong lectin-independent effects on the internal pH-value, presence of a chelating agent does not demonstrate unquestioned evidence suggested in the above experiments.
Keywords: Macrophages, pH, Galectins, biosignaling, Lectins
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
14 Mar 2024 : Clinical Research
Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate...Med Sci Monit In Press; DOI: 10.12659/MSM.943956
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952